Explore the words cloud of the SchmaVirusVacDiag project. It provides you a very rough idea of what is the project "SchmaVirusVacDiag" about.
The following table provides information about the project.
Coordinator |
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS
Organization address contact info |
Coordinator Country | Spain [ES] |
Project website | http://www.cicbiogune.es |
Total cost | 158˙121 € |
EC max contribution | 158˙121 € (100%) |
Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
Code Call | H2020-MSCA-IF-2014 |
Funding Scheme | MSCA-IF-EF-ST |
Starting year | 2015 |
Duration (year-month-day) | from 2015-06-15 to 2017-06-14 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS | ES (DERIO VIZCAYA) | coordinator | 158˙121.00 |
Schmallenberg virus (SV) is a pathogen that has been discovered in European livestock 3 years ago. Since then, it has been found that this virus is associated with disease in sheep, goats and cattle across Europe . In livestock, the symptoms associated with the disease include stillbirths and malformations in newborn animals. The presence of the virus in Spain, France, Germany, Italy, the UK, the Netherlands as well as Russia, has shown that this disease is a fast spreading threat to the European livestock industry, and has the potential to cause significant economic impact across the continent. Furthermore, due to high volumes in international trade of livestock, the potential of this disease to spread beyond Europe poses another potential threat to the industry. Recent work using a related bunyavirus (Rift Valley Fever virus) has found that effective DNA vaccines can be generated . These vaccines have the advantage of being administered easily, having low-manufacturing costs, and providing long-lasting efficacy-making it ideal for large-scale vaccination campaigns. Furthermore, studies on related viruses have shown that monoclonal antibodies can be generated for use in diagnostic testing. Using these concepts, we propose to extend this principle to Schmallenberg virus, in order to: i) develop an easy-to-use diagnostic test for Schmallenberg detection; and ii) develop a DNA vaccination strategy that could be used to limit further future outbreaks.
year | authors and title | journal | last update |
---|---|---|---|
2017 |
Hani Y. Boshra, Diego Charro, Gema Lorenzo, Isbene Sánchez, Beatriz Lazaro, Alejandro Brun, Nicola G.A. Abrescia DNA vaccination regimes against Schmallenberg virus infection in IFNAR −/− mice suggest two targets for immunization published pages: 107-115, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.02.013 |
Antiviral Research 141 | 2019-07-24 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SCHMAVIRUSVACDIAG" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SCHMAVIRUSVACDIAG" are provided by the European Opendata Portal: CORDIS opendata.
Neural mechanisms of crossmodal activity in blind and sighted individuals
Read MoreUltra-high field imaging of perceptual learning and human brain plasticity
Read MoreMonitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells
Read More